Quick Answer
Amrize Ltd reported Cash and Equivalents of $1.92 billion for fiscal year 2025.
Amrize Ltd Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.92B | +21.3% |
| 2024 | $1.58B | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $826.00M | — | +37.4% |
| June 30, 2025 | $601.00M | — | -62.1% |
| December 31, 2024 | $1.58B | — | — |
- Amrize Ltd showed an increase of +21.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2024–2025 period, Amrize Ltd’s cash and equivalents has grown by 21.3% (from $1.58 billion to $1.92 billion).
- The most recent figure is from Amrize Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: